Alps Advisors Inc. acquired a new stake in HilleVax, Inc. (NASDAQ:HLVX – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 19,825 shares of the company's stock, valued at approximately $217,000. Alps Advisors Inc. owned 0.06% of HilleVax at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Frazier Life Sciences Management L.P. acquired a new stake in HilleVax in the second quarter valued at approximately $101,493,000. Strs Ohio acquired a new stake in shares of HilleVax in the second quarter worth approximately $32,000. JPMorgan Chase & Co. acquired a new stake in shares of HilleVax in the second quarter worth approximately $76,000. Finally, TD Asset Management Inc. acquired a new stake in shares of HilleVax in the second quarter worth approximately $203,000.
Get HilleVax alerts:HilleVax Stock Up 0.6 %
Shares of NASDAQ:HLVX opened at $21.15 on Thursday. The company has a quick ratio of 34.77, a current ratio of 34.77 and a debt-to-equity ratio of 0.02. The business's 50 day moving average price is $19.37 and its 200-day moving average price is $14.70. HilleVax, Inc. has a 1 year low of $7.90 and a 1 year high of $24.42.
HilleVax Company Profile
(Get Rating)HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Further Reading
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
Want to see what other hedge funds are holding HLVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HilleVax, Inc. (NASDAQ:HLVX – Get Rating).
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.